Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong

Zhong, 2003, Our strategies for fighting severe acute respiratory syndrome (SARS), Am J Respir Crit Care Med, 168, 7, 10.1164/rccm.200305-707OE Choi, 2003, Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong, Ann Intern Med, 139, 715, 10.7326/0003-4819-139-9-200311040-00005 So, 2003, Development of a standard treatment protocol for severe acute respiratory syndrome, Lancet, 361, 1615, 10.1016/S0140-6736(03)13265-5 Lee, 2003, A major outbreak of severe acute respiratory syndrome in Hong Kong, N Engl J Med, 348, 1986, 10.1056/NEJMoa030685 Ho, 2003, High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome, Am J Respir Crit Care Med, 168, 1449, 10.1164/rccm.200306-766OC Peiris, 2003, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, 361, 1767, 10.1016/S0140-6736(03)13412-5 Lau, 2003, Severe acute respiratory syndrome treatment: present status and future strategy, Curr Opin Investig Drugs, 4, 918 Wong, 2004, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin Exp Immunol, 136, 95, 10.1111/j.1365-2249.2004.02415.x Wong, 2004, Index patient and SARS outbreak in Hong Kong, Emerg Infect Dis, 10, 339, 10.3201/eid1002.030645 Hsu, 2003, Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts, Emerg Infect Dis, 9, 713 Li, 2003, Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report, Chin J Intern Med, 42, 378 Wang, 2003, Fatal aspergillosis in a patient with SARS who was treated with corticosteroids, N Engl J Med, 349, 507, 10.1056/NEJM200307313490519 World Health Organisation Severinghaus, 1978, Estimation of skin metabolism and blood flow with tcPO2 and tcPO2 electrodes by cuff occlusion of the circulation, Acta Anaesthesiol Scand Suppl, 68, 9, 10.1111/j.1399-6576.1978.tb01386.x Bernard, 1994, The American–European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination, Am J Respir Crit Care Med, 149, 818, 10.1164/ajrccm.149.3.7509706 Fowler, 2003, Critically ill patients with severe acute respiratory distress syndrome, JAMA, 290, 363, 10.1001/jama.290.3.367 Lew, 2003, Acute respiratory distress syndrome in critically ill patients with severe acute respiratory distress syndrome, JAMA, 290, 374, 10.1001/jama.290.3.374 Cinatl, 2003, Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus, Lancet, 361, 2045, 10.1016/S0140-6736(03)13615-X Chen, 2004, In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compound, J Clin Virol, 31, 69, 10.1016/j.jcv.2004.03.003 Morgenstern, 2005, Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines, Biochem Biophys Res Commun, 326, 905, 10.1016/j.bbrc.2004.11.128 Jiang, 2005, Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome, Am J Respir Crit Care Med, 17, 850, 10.1164/rccm.200407-857OC Beijing Group of National Research Project of SARS, 2003, Dynamic changes in blood cytokine levels as clinical indicators in severe actue respiratory syndrome, Chin Med J (Engl), 116, 1283 Chan, 2003, Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study, Hong Kong Med J, 9, 399 Langhoff, 1985, The immunosuppressive potency of various steroids on peripheral blood lymphocytes, T cells, NK and K cells, Int J Immunopharmacol, 7, 483, 10.1016/0192-0561(85)90067-0 Langhoff, 1983, Relative immunosuppressive potency of various corticosteroids measured in vitro, Eur J Clin Pharmacol, 25, 459, 10.1007/BF00542111 Sung, 2004, Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak, Thorax, 59, 414, 10.1136/thx.2003.014076 Chan, 2003, Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS), Thorax, 58, 686, 10.1136/thorax.58.8.686 Lau, 2004, Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol, Respirology, 9, 173, 10.1111/j.1440-1843.2004.00588.x Zhao, 2003, Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China, J Med Microbiol, 52, 715, 10.1099/jmm.0.05320-0 Tsui, 2003, Severe acute respiratory syndrome: clinical outcome and prognostic correlates, Emerg Infect Dis, 9, 1064, 10.3201/eid0909.030362 Tsang, 2003, Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality, Emerg Infect Dis, 9, 1381, 10.3201/eid0911.030400 Lee, 2004, Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentration in adult patients, J Clin Virol, 31, 304, 10.1016/j.jcv.2004.07.006 Meduri, 1999, Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria, Am J Respir Crit Care Med, 160, 961, 10.1164/ajrccm.160.3.9807080